Arthur He CFA
Stock Analyst at H.C. Wainwright
(4.87)
# 335
Out of 4,595 analysts
133
Total ratings
57.8%
Success rate
36.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Arthur He CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: MSCL Satellos Bioscience Inc. | Reiterated: Buy | $15.45 → $25.29 | $14.00 | +80.63% | 13 | Jul 9, 2026 | |
| PRME Prime Medicine | Reiterated: Buy | $8 | $2.92 | +173.97% | 17 | Jul 9, 2026 | |
| VERA Vera Therapeutics | Reiterated: Buy | $110 → $125 | $32.10 | +289.41% | 12 | Jul 8, 2026 | |
| NKTR Nektar Therapeutics | Reiterated: Buy | $185 | $70.67 | +161.78% | 18 | Jul 1, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | $25 | $8.06 | +210.17% | 20 | Jul 1, 2026 | |
| JBIO Jade Biosciences | Rated: Buy | $45 → $55 | $19.75 | +178.48% | 5 | Jun 1, 2026 | |
| ADAG Adagene | Reiterated: Buy | $7 | $3.75 | +86.67% | 18 | Apr 7, 2026 | |
| AUPH Aurinia Pharmaceuticals | Reiterated: Buy | $17 | $14.88 | +14.25% | 3 | Feb 27, 2026 | |
| BCAB BioAtla | Reiterated: Hold | n/a | $3.30 | - | 15 | Aug 11, 2025 | |
| ADAPY Adaptimmune Therapeutics plc | Downgraded: Hold | n/a | $0.0318 | n/a | 8 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $24.82 | n/a | 1 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27.00 → $35.00 | $25.30 | n/a | 3 | Apr 3, 2023 |
Satellos Bioscience Inc.
Jul 9, 2026
Reiterated: Buy
Price Target: $15.45 → $25.29
Current: $14.00
Upside: +80.63%
Prime Medicine
Jul 9, 2026
Reiterated: Buy
Price Target: $8
Current: $2.92
Upside: +173.97%
Vera Therapeutics
Jul 8, 2026
Reiterated: Buy
Price Target: $110 → $125
Current: $32.10
Upside: +289.41%
Nektar Therapeutics
Jul 1, 2026
Reiterated: Buy
Price Target: $185
Current: $70.67
Upside: +161.78%
Solid Biosciences
Jul 1, 2026
Reiterated: Buy
Price Target: $25
Current: $8.06
Upside: +210.17%
Jade Biosciences
Jun 1, 2026
Rated: Buy
Price Target: $45 → $55
Current: $19.75
Upside: +178.48%
Adagene
Apr 7, 2026
Reiterated: Buy
Price Target: $7
Current: $3.75
Upside: +86.67%
Aurinia Pharmaceuticals
Feb 27, 2026
Reiterated: Buy
Price Target: $17
Current: $14.88
Upside: +14.25%
BioAtla
Aug 11, 2025
Reiterated: Hold
Price Target: n/a
Current: $3.30
Upside: -
Adaptimmune Therapeutics plc
Jul 29, 2025
Downgraded: Hold
Price Target: n/a
Current: $0.0318
Upside: n/a
Jun 21, 2024
Maintained: Buy
Price Target: n/a
Current: $24.82
Upside: n/a
Apr 3, 2023
Maintained: Buy
Price Target: $27.00 → $35.00
Current: $25.30
Upside: n/a